Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Adv Exp Med Biol ; 1077: 285-306, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30357694

RESUMEN

In order to develop and commercialize for the regenerative medicinal products, smart biomaterials with biocompatibility must be needed. In this chapter, we introduce collagen and hyaluronic acid (HA) as extracellular matrix as well as deal with the molecular mechanism as microenvironment, mechanistic effects, and gene expression. Application of collagen and HA have been reviewed in the area of orthopedics, orthopedics, ophthalmology, dermatology and plastic surgery. Finally, the ongoing and commercial products of collagen and HA for regenerative medicine have been introduced.


Asunto(s)
Materiales Biocompatibles , Colágeno/uso terapéutico , Ácido Hialurónico/uso terapéutico , Medicina Regenerativa/tendencias , Matriz Extracelular , Humanos
2.
J Biomed Sci ; 20: 98, 2013 Dec 20.
Artículo en Inglés | MEDLINE | ID: mdl-24359566

RESUMEN

BACKGROUND: Zinc finger protein 179 (Znf179), also known as ring finger protein 112 (Rnf112), is a member of the RING finger protein family and plays an important role in neuronal differentiation. To investigate novel mechanisms of Znf179 regulation and function, we performed a yeast two-hybrid screen to identify Znf179-interacting proteins. RESULTS: Using a yeast two-hybrid screen, we have identified promyelocytic leukemia zinc finger (Plzf) as a specific interacting protein of Znf179. Further analysis showed that the region containing the first two zinc fingers of Plzf is critical for its interaction with Znf179. Although the transcriptional regulatory activity of Plzf was not affected by Znf179 in the Gal4-dependent transcription assay system, the cellular localization of Znf179 was changed from cytoplasm to nucleus when Plzf was co-expressed. We also found that Znf179 interacted with Plzf and regulated Plzf protein expression. CONCLUSIONS: Our results showed that Znf179 interacted with Plzf, resulting in its translocation from cytoplasm to the nucleus and increase of Plzf protein abundance. Although the precise nature and role of the Znf179-Plzf interaction remain to be elucidated, both of these two genes are involved in the regulation of neurogenesis. Our finding provides further research direction for studying the molecular functions of Znf179.


Asunto(s)
Núcleo Celular/metabolismo , Citoplasma/metabolismo , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Factores de Transcripción de Tipo Kruppel/genética , Técnica del Anticuerpo Fluorescente , Células HeLa , Humanos , Inmunoprecipitación , Factores de Transcripción de Tipo Kruppel/metabolismo , Proteína de la Leucemia Promielocítica con Dedos de Zinc , Unión Proteica , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transfección , Técnicas del Sistema de Dos Híbridos
3.
Phys Chem Chem Phys ; 15(7): 2495-506, 2013 Feb 21.
Artículo en Inglés | MEDLINE | ID: mdl-23318504

RESUMEN

The oppositely oriented lamellae in ridge and valley bands of ring-banded spherulites in biodegradable poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) (PHBV) interacting with amorphous poly(vinyl acetate) (PVAc) were examined using polarized-light optical, scanning electron, and atomic-force microscopy techniques (POM, SEM, AFM). Solvent-etching and fracturing were utilized for probing the interior morphology of the large-size ring-banded spherulites in PHBV/PVAc (70/30) blend [T(c) = 110 °C] films or thick bulk of various thicknesses. SEM analysis revealed that dual ridges of two opposite-oriented lamellae correspond to two-color bands (yellow and blue) of successive rings in POM micrographs. Fracture of thick blend samples further exposed that interior 3D spherulites were composed of sheath-kebab (similar to corrugated board) lamellae of two mutually perpendicular orientations.


Asunto(s)
Poliésteres/química , Cristalización , Microscopía de Fuerza Atómica , Microscopía Electrónica de Rastreo , Solventes/química , Propiedades de Superficie
4.
Biochem J ; 441(1): 367-77, 2012 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-21883094

RESUMEN

MTF-1 (metal-responsive transcription factor 1) is an essential mammalian protein for embryonic development and modulates the expression of genes involving in zinc homoeostasis and responding to oxidative stress. We report in the present paper that PTEN (phosphatase and tensin homologue deleted on chromosome 10) associates with MTF-1 in the cells. These two proteins interact via the acidic domain of MTF-1 and the phosphatase/C2 domain of PTEN. Depletion of PTEN reduced MT (metallothionein) gene expression and increased cellular sensitivity to cadmium toxicity. PTEN did not alter the nuclear translocation, protein stability or DNA-binding activity of MTF-1. Zinc increased MTF-1-PTEN interaction in a dose-dependent manner. The interaction elevated within 2 h of zinc addition and declined afterwards in the cells. The enhanced binding activity occurred mainly in the cytoplasm and reduced after translocating the MTF-1 into the nucleus. Blocking signalling through the PI3K (phosphoinositide 3-kinase) pathway did not alter the zinc-induced MT expression. Analysis of enzymatically inactive PTEN mutants demonstrated that protein but not lipid phosphatase activity of PTEN was involved in the regulation of MTF-1 activity. The same regulatory role of PTEN was also noted in the regulation of ZnT1 (zinc transporter 1), another target gene of MTF-1.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Fosfohidrolasa PTEN/metabolismo , Factores de Transcripción/metabolismo , Transcripción Genética/fisiología , Animales , Células CHO , Cadmio , Proteínas de Transporte de Catión , Cricetinae , Proteínas de Unión al ADN/genética , Regulación del Desarrollo de la Expresión Génica , Células HEK293 , Homeostasis , Humanos , Metalotioneína/genética , Metalotioneína/metabolismo , Ratones , Fosfohidrolasa PTEN/genética , Factores de Transcripción/genética , Zinc/metabolismo , Factor de Transcripción MTF-1
5.
Eur J Hosp Pharm ; 29(6): 324-328, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-33608396

RESUMEN

OBJECTIVES: In children, supraventricular tachycardia is the most common form of arrhythmia, and propafenone is an effective class Ic antiarrhythmic agent used in this population. No suitable paediatric-specific, dosing-flexible preparation is available in Taiwan. The objective of this study was to develop a formulation of propafenone oral suspension prepared from commercially available propafenone tablets and commercially available oral syrup vehicles for related patients. METHODS: An oral suspension of propafenone hydrochloride at a concentration of 10 mg/mL was prepared by mixing finely grounded propafenone hydrochloride tablets and a 1:1 mixture of Ora-Plus and Ora-Sweet. The beyond-use date was determined by analysing the samples stored at room temperature or 2-8℃ at time 0 and on days 7, 14, 21, 28, 35, 42, 56, and 90. Parameters to be inspected included appearance, pH measurement, high-performance liquid chromatography analysis, and microbial limit tests. RESULTS: On the basis of the physicochemical and microbial stability results, the 10 mg/mL oral suspension of propafenone hydrochloride was stable at 2-8℃ and room temperature for at least 90 days. The suspension did not exhibit significant changes in drug concentration or pH level at any time point. Moreover, no apparent changes or microbial contaminations were observed for at least 90 days. CONCLUSIONS: Propafenone hydrochloride in a 10 mg/mL oral suspension prepared by diluting fine powder with a 1:1 mixture of Ora-Plus and Ora-Sweet and stored in high-density polyethylene bottles and has a beyond-use date of 90 days when stored at 2-8℃ or room temperature. This finding enables us to improve the accuracy of dosage administration and reduce the risk of medication errors affecting the paediatric population.


Asunto(s)
Polietileno , Propafenona , Humanos , Niño , Estabilidad de Medicamentos , Composición de Medicamentos , Polvos , Administración Oral , Vehículos Farmacéuticos/química , Suspensiones , Arritmias Cardíacas
6.
Pediatr Neonatol ; 61(3): 331-337, 2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-32199865

RESUMEN

BACKGROUND: Preterm infants require higher calcium and phosphate intake than term infants to facilitate adequate bone growth, but this is rarely met in parenteral nutrition (PN) solution because of the limited solubility of calcium and phosphate. This study aimed to evaluate the solubility of organic phosphate with calcium gluconate in neonatal PN solutions, simulating its clinical use. METHODS: PN solutions were composed of calcium gluconate at 50 mEq/L and sodium glycerophosphate (NaGP) at 25 mmol/L. Another component included 1% or 4% amino acid and 10% or 20% dextrose. For comparison, PN solution composed of potassium phosphate was also evaluated. Each solution was evaluated using the following methods: visual inspection, light obscuration particle count test, and pH measurement. To simulate the clinical condition, the solution was tested after compounding, after being stored at 25 °C for 24 h, and after being stored at 2°C-8°C for 2 or 9 days and subsequently at 25 °C for 24 h. RESULTS: There was no visual deposition in PN solution using NaGP in any of the concentrations and under any stored condition. The solution fulfilled the criteria of physical compatibility as < 25 particles/mL measuring ≥10 µm in diameter and <3 particles/mL measuring ≥25 µm in diameter. On the contrary, visual deposition was evidently noted in PN solution using potassium phosphate after its formulation, and the particle count significantly exceeded the range of physical compatibility. CONCLUSION: NaGP and calcium gluconate have significantly good compatibility in PN solution. The use of NaGP in neonatal PN prevents calcium and phosphorus precipitation, hence increasing their supply to preterm infants in meeting their growth requirement.


Asunto(s)
Calcio/química , Glicerofosfatos/química , Soluciones para Nutrición Parenteral/química , Fosfatos/química , Humanos , Recién Nacido/crecimiento & desarrollo , Recien Nacido Prematuro , Solubilidad
7.
Sci Rep ; 6: 37659, 2016 11 29.
Artículo en Inglés | MEDLINE | ID: mdl-27898058

RESUMEN

Many neurodegenerative diseases are accompanied by metabolic disorders. CCL5/RANTES, and its receptor CCR5 are known to contribute to neuronal function as well as to metabolic disorders such as type 2 diabetes mellitus, obesity, atherosclerosis and metabolic changes after HIV infection. Herein, we found that the lack of CCR5 or CCL5 in mice impaired regulation of energy metabolism in hypothalamus. Immunostaining and co-immunoprecipitation revealed the specific expression of CCR5, associated with insulin receptors, in the hypothalamic arcuate nucleus (ARC). Both ex vivo stimulation and in vitro tissue culture studies demonstrated that the activation of insulin, and PI3K-Akt pathways were impaired in CCR5 and CCL5 deficient hypothalamus. The inhibitory phosphorylation of insulin response substrate-1 at Ser302 (IRS-1S302) but not IRS-2, by insulin was markedly increased in CCR5 and CCL5 deficient animals. Elevating CCR5/CCL5 activity induced GLUT4 membrane translocation and reduced phospho-IRS-1S302 through AMPKα-S6 Kinase. Blocking CCR5 using the antagonist, MetCCL5, abolished the de-phosphorylation of IRS-1S302 and insulin signal activation. In addition, intracerebroventricular delivery of MetCCL5 interrupted hypothalamic insulin signaling and elicited peripheral insulin responsiveness and glucose intolerance. Taken together, our data suggest that CCR5 regulates insulin signaling in hypothalamus which contributes to systemic insulin sensitivity and glucose metabolism.


Asunto(s)
Quimiocina CCL5/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Metabolismo Energético/genética , Insulina/metabolismo , Animales , Núcleo Arqueado del Hipotálamo/metabolismo , Núcleo Arqueado del Hipotálamo/patología , Quimiocina CCL5/antagonistas & inhibidores , Quimiocina CCL5/genética , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/patología , Modelos Animales de Enfermedad , Transportador de Glucosa de Tipo 4/genética , Humanos , Hipotálamo/metabolismo , Hipotálamo/patología , Insulina/genética , Ratones , Neuronas/metabolismo , Neuronas/patología , Fosfatidilinositol 3-Quinasas/genética , Fosforilación , Receptor de Insulina/genética , Receptor de Insulina/metabolismo , Transducción de Señal/genética
8.
J Nat Prod ; 71(2): 179-85, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18198839

RESUMEN

Chemical investigation of a Formosan soft coral, Sinularia gibberosa, has led to the isolation of eight oxygenated cembranoids, 1- 8, including seven new compounds, gibberosenes A-G ( 2- 8). None of these compounds were found to be cytotoxic toward a limited panel of cancer cell lines. Compound 1 significantly inhibited the accumulation of the pro-inflammatory COX-2 protein of the LPS-stimulated RAW264.7 macrophage cells.


Asunto(s)
Antozoos/química , Antiinflamatorios no Esteroideos/aislamiento & purificación , Diterpenos/aislamiento & purificación , Animales , Antiinflamatorios no Esteroideos/química , Antiinflamatorios no Esteroideos/farmacología , Carboxipeptidasas , Carboxipeptidasas A/efectos de los fármacos , Carboxipeptidasas A/metabolismo , Simulación por Computador , Diterpenos/química , Diterpenos/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Concentración 50 Inhibidora , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Ratones , Estructura Molecular , Oxígeno/química , Taiwán
9.
J Nat Prod ; 69(9): 1275-9, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16989519

RESUMEN

Chemical investigation on the dichloromethane-soluble fraction from the EtOH extract of Sinularia gibberosa Tixier-Durivault has led to the isolation of three new polyoxygenated sterols, gibberoketosterols B (1) and C (2) and gibberoepoxysterol (3), along with two known steroids, gibberoketosterol (4) and 24-methylenecholest-5-en-3beta-ol (5). These cholestane-type sterols possessing a 22,24(28)-conjugated diene (1 and 2) in the side chain or a 5alpha,6alpha-epoxide in the B-ring (3) were isolated for the first time from marine sources. Compound 4 showed significant inhibition against the up-regulation of the pro-inflammatory iNOS and COX-2 proteins of LPS-stimulated RAW264.7 macrophage cells, while 1 was found to be inactive. The cytotoxicity of 1-4 toward a limited panel of cancer cell lines is also reported.


Asunto(s)
Antozoos/química , Inhibidores de la Ciclooxigenasa 2 , Esteroles , Animales , Inhibidores de la Ciclooxigenasa 2/química , Inhibidores de la Ciclooxigenasa 2/aislamiento & purificación , Inhibidores de la Ciclooxigenasa 2/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Estructura Molecular , Óxido Nítrico Sintasa de Tipo II/efectos de los fármacos , Esteroles/química , Esteroles/aislamiento & purificación , Esteroles/farmacología , Taiwán , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA